345 related articles for article (PubMed ID: 12549788)
1. The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis.
Tapaneya-Olarn W; Khositseth S; Tapaneya-Olarn C; Teerakarnjana N; Chaichanajarernkul U; Stitchantrakul W; Petchthong T
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1143-9. PubMed ID: 12549788
[TBL] [Abstract][Full Text] [Related]
2. Dosage of potassium citrate in the correction of urinary abnormalities in pediatric distal renal tubular acidosis patients.
Domrongkitchaiporn S; Khositseth S; Stitchantrakul W; Tapaneya-olarn W; Radinahamed P
Am J Kidney Dis; 2002 Feb; 39(2):383-91. PubMed ID: 11840381
[TBL] [Abstract][Full Text] [Related]
3. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
[TBL] [Abstract][Full Text] [Related]
4. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
5. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
6. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
[TBL] [Abstract][Full Text] [Related]
7. Bone histology and bone mineral density after correction of acidosis in distal renal tubular acidosis.
Domrongkitchaiporn S; Pongskul C; Sirikulchayanonta V; Stitchantrakul W; Leeprasert V; Ongphiphadhanakul B; Radinahamed P; Rajatanavin R
Kidney Int; 2002 Dec; 62(6):2160-6. PubMed ID: 12427141
[TBL] [Abstract][Full Text] [Related]
8. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
9. [Renal tubular function in children with hypercalciuria].
Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
[TBL] [Abstract][Full Text] [Related]
10. Persistent and transient distal renal tubular acidosis with bicarbonate wasting.
Leumann EP; Steinmann B
Pediatr Res; 1975 Oct; 9(10):767-73. PubMed ID: 241961
[TBL] [Abstract][Full Text] [Related]
11. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
12. [Infantile transitory distal renal tubular acidosis with bicarbonate loss].
Schabel F; Irnberger E
Padiatr Padol; 1985; 20(4):353-62. PubMed ID: 2867514
[TBL] [Abstract][Full Text] [Related]
13. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
Sakhaee K; Poindexter JR; Griffith CS; Pak CY
J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome in children with primary distal renal tubular acidosis.
Bajpai A; Bagga A; Hari P; Bardia A; Mantan M
Indian Pediatr; 2005 Apr; 42(4):321-8. PubMed ID: 15876593
[TBL] [Abstract][Full Text] [Related]
15. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
[TBL] [Abstract][Full Text] [Related]
16. Effect of potassium citrate therapy on the risk of renal stone formation during spaceflight.
Whitson PA; Pietrzyk RA; Jones JA; Nelman-Gonzalez M; Hudson EK; Sams CF
J Urol; 2009 Nov; 182(5):2490-6. PubMed ID: 19765769
[TBL] [Abstract][Full Text] [Related]
17. Alkali absorption and citrate excretion in calcium nephrolithiasis.
Sakhaee K; Williams RH; Oh MS; Padalino P; Adams-Huet B; Whitson P; Pak CY
J Bone Miner Res; 1993 Jul; 8(7):789-94. PubMed ID: 8352061
[TBL] [Abstract][Full Text] [Related]
18. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children.
Sarica K; Erturhan S; Yurtseven C; Yagci F
J Endourol; 2006 Nov; 20(11):875-9. PubMed ID: 17144854
[TBL] [Abstract][Full Text] [Related]
19. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation.
Robinson MR; Leitao VA; Haleblian GE; Scales CD; Chandrashekar A; Pierre SA; Preminger GM
J Urol; 2009 Mar; 181(3):1145-50. PubMed ID: 19152932
[TBL] [Abstract][Full Text] [Related]
20. [Renal acidification mechanism disorders in patients with osteoporosis].
Sánchez A; Libman J
Medicina (B Aires); 1995; 55(3):197-202. PubMed ID: 8544715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
